Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Dividends Paid - Common: 2009-2025

Historic Dividends Paid - Common for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $12.4 million.

  • BIO-TECHNE's Dividends Paid - Common fell 1.92% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.1 million, marking a year-over-year decrease of 0.61%. This contributed to the annual value of $50.4 million for FY2025, which is 0.06% down from last year.
  • BIO-TECHNE's Dividends Paid - Common amounted to $12.4 million in Q3 2025, which was up 0.46% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Dividends Paid - Common ranged from a high of $12.7 million in Q4 2024 and a low of $12.4 million during Q2 2025.
  • In the last 3 years, BIO-TECHNE's Dividends Paid - Common had a median value of $12.6 million in 2023 and averaged $12.6 million.
  • As far as peak fluctuations go, BIO-TECHNE's Dividends Paid - Common climbed by 1.55% in 2021, and later decreased by 1.92% in 2025.
  • Over the past 5 years, BIO-TECHNE's Dividends Paid - Common (Quarterly) stood at $12.6 million in 2021, then dropped by 0.12% to $12.6 million in 2022, then decreased by 0.02% to $12.6 million in 2023, then grew by 1.41% to $12.7 million in 2024, then decreased by 1.92% to $12.4 million in 2025.
  • Its Dividends Paid - Common stands at $12.4 million for Q3 2025, versus $12.4 million for Q2 2025 and $12.6 million for Q1 2025.